rawfin.tv
Innovative Cellular Transfers 38,500 Lyell Immunopharma Shares
MarketsstocksAI Generated

Innovative Cellular Transfers 38,500 Lyell Immunopharma Shares

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Innovative Cellular Therapeutics Holdings Ltd, a 10% owner of Lyell Immunopharma (LYEL), executed a transfer of 38,500 shares. This transaction represents a notable change in holdings by a significant stakeholder.

LYELInsider TradingShare TransferBiotechnologyStock Data

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks